GSK "well positioned" to weather pharma tariffs
GSK has posted a solid set of financial results in the first quarter of this year and said it is not too worried about the financial impact of potential pharma-specific US tariff rules. The UK-headquartered group said total sales rose 4% to £7.52 billion ( …